Clynes M - Search Results

1

Examining the relationship between cancer invasion/metastasis and drug resistance.

Liang Y, McDonnell S, Clynes M. Liang Y, et al. Among authors: clynes m. Curr Cancer Drug Targets. 2002 Sep;2(3):257-77. doi: 10.2174/1568009023333872. Curr Cancer Drug Targets. 2002. PMID: 12188911 Review.

2

Multiple drug resistance-related messenger RNA expression in archival formalin-fixed paraffin-embedded human breast tumour tissue.

O'Driscoll L, Kennedy S, McDermott E, Kelehan P, Clynes M. O'Driscoll L, et al. Among authors: clynes m. Eur J Cancer. 1996 Jan;32A(1):128-33. doi: 10.1016/0959-8049(95)00552-8. Eur J Cancer. 1996. PMID: 8695220

3

mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines.

Daly C, Coyle S, McBride S, O'Driscoll L, Daly N, Scanlon K, Clynes M. Daly C, et al. Among authors: clynes m. Cytotechnology. 1996;19(3):199-205. doi: 10.1007/BF00744213. Cytotechnology. 1996. PMID: 8862007

4

Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance.

Heenan M, O'Driscoll L, Cleary I, Connolly L, Clynes M. Heenan M, et al. Among authors: clynes m. Int J Cancer. 1997 May 29;71(5):907-15. doi: 10.1002/(sici)1097-0215(19970529)71:5<907::aid-ijc33>3.0.co;2-1. Int J Cancer. 1997. PMID: 9180164

5

Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).

Duffy CP, Elliott CJ, O'Connor RA, Heenan MM, Coyle S, Cleary IM, Kavanagh K, Verhaegen S, O'Loughlin CM, NicAmhlaoibh R, Clynes M. Duffy CP, et al. Among authors: clynes m. Eur J Cancer. 1998 Jul;34(8):1250-9. doi: 10.1016/s0959-8049(98)00045-8. Eur J Cancer. 1998. PMID: 9849488

6

Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA.

NicAmhlaoibh R, Heenan M, Cleary I, Touhey S, O'Loughlin C, Daly C, Nuñez G, Scanlon KJ, Clynes M. NicAmhlaoibh R, et al. Among authors: clynes m. Int J Cancer. 1999 Jul 30;82(3):368-76. doi: 10.1002/(sici)1097-0215(19990730)82:3<368::aid-ijc10>3.0.co;2-e. Int J Cancer. 1999. PMID: 10399954

7

Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness.

Liang Y, Meleady P, Cleary I, McDonnell S, Connolly L, Clynes M. Liang Y, et al. Among authors: clynes m. Eur J Cancer. 2001 May;37(8):1041-52. doi: 10.1016/s0959-8049(01)00086-7. Eur J Cancer. 2001. PMID: 11334731

8

Structure-activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition. identification of novel chemotherapeutic drug resistance modulators.

Touhey S, O'Connor R, Plunkett S, Maguire A, Clynes M. Touhey S, et al. Among authors: clynes m. Eur J Cancer. 2002 Aug;38(12):1661-70. doi: 10.1016/s0959-8049(02)00128-4. Eur J Cancer. 2002. PMID: 12142058

9

Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro.

O'Driscoll L, Linehan R, Liang YH, Joyce H, Oglesby I, Clynes M. O'Driscoll L, et al. Among authors: clynes m. Anticancer Res. 2002 Nov-Dec;22(6A):3117-25. Anticancer Res. 2002. PMID: 12530054

10

Survivin: role in normal cells and in pathological conditions.

O'Driscoll L, Linehan R, Clynes M. O'Driscoll L, et al. Among authors: clynes m. Curr Cancer Drug Targets. 2003 Apr;3(2):131-52. doi: 10.2174/1568009033482038. Curr Cancer Drug Targets. 2003. PMID: 12678716 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters